STOCK TITAN

Skylight Health Names Paul Kulas Senior Vice President of Operations

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Skylight Health Group (TSXV:SHG; OTCQX:SHGFF) has appointed Paul Kulas as Senior Vice President of Operations. Kulas brings 28 years of experience in integrated healthcare systems, overseeing over 350 providers. His past role at St. Joseph Health Medical Group emphasized operational leadership. At Skylight, he aims to enhance clinic operations and increase profitability through technology and operational synergies. The company also granted 600,000 stock options at an exercise price of $1.50. Skylight operates a multi-state network of clinics and offers telemedicine services to 155,000 patients across 16 states.

Positive
  • Appointment of Paul Kulas as Senior VP of Operations, bringing extensive healthcare experience.
  • Focus on enhancing clinic operations and improving profitability through operational synergies.
  • Active patient roster of over 155,000 across 16 states, indicating strong market presence.
Negative
  • No significant negative aspects reported.

TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG ; OTCQX:SHGFF) (“Skylight Health” or the “Company”), announced today that Paul Kulas joins Skylight Health executive team as Senior Vice President of Operations.

Mr. Kulas has a diverse background in large integrated healthcare systems, and brings 28 years of experience and strong relationships:

  • Accountable to over 350 providers and 275 provider affiliates across the United States.
  • Implemented Telehealth services to entire region of Northern California.
  • Successful implementation of new technology and information systems.
  • Oversaw provider contracting, physician compensation, and productivity models.

Most recently, Mr. Kulas acted as VP of Operations for St. Joseph Health Medical Group, a member of Providence. Providence is one of the largest healthcare networks in the United States with over 120,000 caregivers serving in 51 hospitals, 1,085 clinics and offers a comprehensive range of health and social services to its 5 million unique patients across Alaska, California, Montana, New Mexico, Oregon, Texas and Washington.

In his role at Skylight Health, Mr. Kulas will be responsible for development, expansion and management of Skylight Health clinic operations, nationally. Mr. Kulas will lead the strategic design and development of a network of clinics, with P/L responsibility, and will be responsible for ensuring optimal configuration and operations to promote a high quality and consistent care experience, for practitioners and clients.

“I am thrilled to have an executive of Paul’s caliber and experience join our growing team,” says Prad Sekar, Co-Founder and CEO of Skylight Health. “Throughout his career, he has proven to be a highly effective leader, driving transformation, and instilling operational rigor to efficiently deliver results. I look forward to Paul’s active leadership and believe his experience and relationships within the healthcare industry will be crucial to our accelerated growth.”

“I look forward to refining the business processes already in place at Skylight Health by streamlining our existing business with additional technology enhancements,” says Paul Kulas, SVP Operations of Skylight Health. “My goal is increase profitability through operational synergies as we expand our reach across the United States.”

Mr. Kulas holds a Master of Science in Administration from Central Michigan University, and a Bachelor of Science with a Health Systems Management major from Ferris State University. He has acted as Adjunct Faculty Professor at Eastern Michigan University, College of Health Professions and Adjunct Faculty Professor at Baker College, Health Care Administration.

In addition, under its existing stock option plan, the company has granted certain consultants 600,000 stock options at an exercise price of $1.50.

About Skylight Health Group

Skylight Health Group (TSXV:SHG ; OTCQX:SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. With a patient roster of over 155,000 patients, the Company’s operations servicing 16 states and continues to expand in services and locations both organically and by way of strategic acquisitions.

The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.

For more information, please visit www.skylighthealthgroup.com or contact:

Investor Relations:
Jackie Kelly
investors@skylighthealthgroup.com
416-301-2949

Currency Usage, Cautionary and Forward-Looking Statements

All currency contained in this Press Release represent Canadian Dollars unless otherwise stated.

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health's filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding the Company's unaudited financial results and projected growth.

Financial forecasts in this release are based on the current revenue run rate of Skylight Health, all of its recently completed acquisitions, and its pending acquisitions. This forecast is subject to the closing of any and all pending acquisitions, and successful integration of all its current and future acquisitions without any loss or interruptions of revenues during the integration and transition process. The Company may revise this forecast from time to time and investors should not solely rely on this forward-looking guidance when making an investment decision.

Although Skylight Health has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the ability of Skylight Health to execute on its business strategy, continued revenue growth in accordance with management’s expectations, operating expenses continuing in accordance with management expectations, dependence on obtaining regulatory approvals; Skylight Health being able to find, complete and effectively integrate target acquisitions; change in laws relating to health care regulation; reliance on management; requirements for additional financing; competition; hindering market growth or other factors that may not currently be known by the Company.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


FAQ

Who is Paul Kulas and what is his role at Skylight Health Group?

Paul Kulas is appointed as Senior Vice President of Operations at Skylight Health Group, bringing 28 years of experience in healthcare.

What are the primary responsibilities of Paul Kulas at Skylight Health Group?

Kulas is responsible for the development, expansion, and management of Skylight Health clinic operations nationwide.

What financial incentives were granted by Skylight Health Group?

Skylight Health granted 600,000 stock options at an exercise price of $1.50 under its existing stock option plan.

How many patients does Skylight Health Group serve?

Skylight Health Group serves over 155,000 patients across 16 states.

What is the business model of Skylight Health Group?

Skylight Health primarily operates a traditional fee-for-service model and offers a subscription-based telemedicine service.

SHGFF

:SHGFF

SHGFF Rankings

SHGFF Latest News

SHGFF Stock Data